THE TGA has for the first time
ever registered a herbal medicine
based on its efficacy, via the new
registration pathway for
complementary medicines.
Flordis’ Iberogast has been
registered for the treatment of
functional dyspepsia and Irritable
Bowel Sydrome, with the AUST R
designation meaning the TGA has
evaluated the herbal product for
efficacy as well as safety.
Most complementary medicines
have an AUST L listing, meaning
the TGA hasn’t evaluated efficacy.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 10
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.